Combinatorial Evaluation of Antiviral Activity of some Nigerian Medicinal Plants on SARS-CoV-2Combinatorial Evaluation of Antiviral Activity of some Nigerian Medicinal Plants on SARS-CoV-2
Kakjing D. Falang, Catherine O. Poyi, Ukpe Ajima, Bukata B. Bukar, Kennedy I. Amagon, James G. Damen, Yusuf Agabi, Richard J. Kutshik, Ishaya Y. Longdet, Simji S. Gomerep, Ismaila Shittu, Stephen D. Davou, Jacob A. Kolawole, Noel N. Wannang
Journal of Complementary and Alternative Medical Research · pp. 38–50 · Published 16 Dec 2020
10.9734/jocamr/2020/v12i130199Abstract
The coronavirus disease COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) has presented unprecedented challenges to the healthcare systems in the world. There are no definite effective therapeutic agents or vaccines against the virus currently. However clinical management of the infection includes prevention, control measures, supportive care and repurposed drug therapy based on pathophysiology of the virus and manifestation of the disease condition thereby using antiviral agents such as remdesivir, lopinavir and favipiravir. Herbal preparations are being promoted for the management of Covid-19. Some selected Nigerian medicinal plants are hereby investigated by In-silico studies of the plant constituents. When compared with the listed therapeutic agents, the phytochemical constituents of the selected plants have better binding affinity to several Covid-19 viral target proteins. Also they were found to be safe for human use with LD50 of >2000 mg/Kg for the plant extracts. Some of the plants also contained phytochemicals that can be employed for the symptoms of covid-19.
Cited by 4
C. Meseko, I. Shittu, O. Asala · Onderstepoort Journal of Veterinary Research · 2024
Adedayo Ayodeji Lanrewaju, A. Enitan-Folami, M. Nyaga · Journal of Biomolecular Structure and Dynamics · 2023
A. Boadu, Clement Agoni, R. Karpoormath · Scientific Reports · 2022
B. Najar, Giulia Mecacci, Valeria Nardi · Molecules · 2021
Related research
- COVID 19 Disease Caused by Coronavirus 2 (SARS-CoV-2) (Severe Acute Respiratory Syndrome) — shares topic coverage
- Assessment of Anxiety in Healthcare Providers Working in ICU during COVID-19 Pandemics — shares topic coverage
- Azithromycin and Hydroxychloroquine Accelerate Recovery of Outpatients with Mild/Moderate COVID-19 — shares topic coverage
- Elevated Levels of Lactate Dehydrogenase Predicts Poor Outcomes for Patients with COVID-19: A Review — shares topic coverage
- Addressing the Challenges of Containing Covid-19 Spread in a Rural, Poor Area in India: A Case Study — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
4
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.